OPKO Health to Report Fourth Quarter 2024 Financial Results on February 27, 2025
OPKO Health (NASDAQ: OPK) has announced it will release its fourth quarter and full-year 2024 financial results on February 27, 2025, after U.S. market close. The company will host a conference call and live audio webcast at 4:30 p.m. Eastern time on the same day, where senior management will provide a business update, discuss results, and share financial guidance.
Participants can pre-register for the conference call through a provided link to receive immediate access. Those unable to pre-register can dial 833-630-0584 (U.S.) or 412-317-1815 (International). A telephone replay will be available until March 6, 2025, and a webcast replay will be accessible approximately one hour after the live call.
OPKO Health (NASDAQ: OPK) ha annunciato che pubblicherà i risultati finanziari del quarto trimestre e dell'intero anno 2024 il 27 febbraio 2025, dopo la chiusura del mercato statunitense. L'azienda ospiterà una conferenza telefonica e un webcast audio dal vivo alle 16:30 ora orientale dello stesso giorno, durante la quale il management senior fornirà un aggiornamento sull'azienda, discuterà i risultati e condividerà le previsioni finanziarie.
I partecipanti possono pre-registrarsi per la conferenza telefonica tramite un link fornito per ricevere accesso immediato. Coloro che non possono pre-registrarsi possono comporre il numero 833-630-0584 (USA) o 412-317-1815 (Internazionale). Una registrazione telefonica sarà disponibile fino al 6 marzo 2025, e una registrazione del webcast sarà accessibile circa un'ora dopo la chiamata dal vivo.
OPKO Health (NASDAQ: OPK) ha anunciado que publicará sus resultados financieros del cuarto trimestre y del año completo 2024 el 27 de febrero de 2025, después del cierre del mercado estadounidense. La compañía llevará a cabo una conferencia telefónica y un webcast de audio en vivo a las 4:30 p.m. hora del Este el mismo día, donde la alta dirección proporcionará una actualización del negocio, discutirá los resultados y compartirá las proyecciones financieras.
Los participantes pueden pre-registrarse para la conferencia telefónica a través de un enlace proporcionado para recibir acceso inmediato. Aquellos que no puedan pre-registrarse pueden marcar el 833-630-0584 (EE.UU.) o el 412-317-1815 (Internacional). Una grabación telefónica estará disponible hasta el 6 de marzo de 2025, y una grabación del webcast estará accesible aproximadamente una hora después de la llamada en vivo.
OPKO Health (NASDAQ: OPK)는 2025년 2월 27일에 미국 시장 마감 후 2024년 4분기 및 연간 재무 결과를 발표할 것이라고 발표했습니다. 회사는 같은 날 동부 표준시 기준 오후 4시 30분에 경영진이 사업 업데이트를 제공하고, 결과를 논의하며 재무 지침을 공유하는 전화 회의 및 실시간 오디오 웹캐스트를 개최할 것입니다.
참가자는 즉시 접근을 받을 수 있도록 제공된 링크를 통해 전화 회의에 사전 등록할 수 있습니다. 사전 등록을 하지 못한 경우, 833-630-0584 (미국) 또는 412-317-1815 (국제)로 전화하실 수 있습니다. 전화 재생은 2025년 3월 6일까지 이용 가능하며, 웹캐스트 재생은 실시간 호출 약 한 시간 후에 접근할 수 있습니다.
OPKO Health (NASDAQ: OPK) a annoncé qu'elle publiera ses résultats financiers du quatrième trimestre et de l'année complète 2024 le 27 février 2025, après la fermeture du marché américain. La société organisera une conférence téléphonique et un webinaire audio en direct à 16h30, heure de l'Est, le même jour, où la direction supérieure fournira une mise à jour sur l'entreprise, discutera des résultats et partagera des prévisions financières.
Les participants peuvent se préinscrire à la conférence téléphonique via un lien fourni pour recevoir un accès immédiat. Ceux qui ne peuvent pas se préinscrire peuvent composer le 833-630-0584 (États-Unis) ou le 412-317-1815 (International). Un enregistrement téléphonique sera disponible jusqu'au 6 mars 2025, et un enregistrement du webinaire sera accessible environ une heure après l'appel en direct.
OPKO Health (NASDAQ: OPK) hat angekündigt, dass am 27. Februar 2025 nach Börsenschluss in den USA die Finanzzahlen für das vierte Quartal und das Gesamtjahr 2024 veröffentlicht werden. Das Unternehmen wird am selben Tag um 16:30 Uhr Eastern Time eine Telefonkonferenz und einen Live-Audio-Webcast abhalten, in dem das obere Management ein Update zum Geschäft gibt, die Ergebnisse erörtert und finanzielle Prognosen teilt.
Teilnehmer können sich über einen bereitgestellten Link für die Telefonkonferenz vorregistrieren, um sofortigen Zugang zu erhalten. Wer sich nicht vorregistrieren kann, kann die Nummer 833-630-0584 (USA) oder 412-317-1815 (international) anrufen. Eine Telefonaufzeichnung wird bis zum 6. März 2025 verfügbar sein, und eine Aufzeichnung des Webcasts wird ungefähr eine Stunde nach dem Live-Anruf zugänglich sein.
- None.
- None.
MIAMI, Feb. 13, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three and 12 months ended December 31, 2024 after the close of the U.S. financial markets on Thursday, February 27, 2025. OPKO’s senior management will provide a business update and discuss results as well as financial guidance during a conference call and live audio webcast on February 27th beginning at 4:30 p.m. Eastern time.
CONFERENCE CALL & WEBCAST INFORMATION
OPKO encourages participants to pre-register for the conference call using this link. Callers who pre-register will receive a unique PIN to gain immediate access to the call and bypass the live operator. Participants may register at any time, including up to and after the call start time. Those unable to pre-register may participate by dialing 833-630-0584 (U.S.) or 412-317-1815 (International). A webcast of the call can also be accessed at OPKO’s Investor Relations page and here.
A telephone replay will be available until March 6, 2025, by dialing 877-344-7529 (U.S.) or 412-317-0088 (International) and providing the passcode 8087517. A webcast replay will be available beginning approximately one hour after the completion of the live conference call here.
About OPKO Health
OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies. For more information, visit www.opko.com.
Contacts:
Alliance Advisors IR
Yvonne Briggs, 310-691-7100
ybriggs@allianceadvisors.com
or
Bruce Voss, 310-691-7100
bvoss@allianceadvisors.com
FAQ
When will OPKO Health (OPK) release Q4 2024 earnings?
What time is OPKO Health's (OPK) Q4 2024 earnings call?
How can investors access OPKO Health's (OPK) Q4 2024 earnings call?
How long will OPKO Health's (OPK) Q4 2024 earnings call replay be available?
